XenoTech Named Best In Vitro Drug CRO 2019

XenoTech has been named the Best In Vitro Drug CRO in the 2019 Healthcare & Pharmaceutical Awards. From the release:

The responsibility for maintaining and improving the health of millions of individuals worldwide cannot be taken lightly as it is a duty fraught with many challenges and obstacles. In their bid to remain at the forefront in fight against disease and illness while providing cutting edge solutions for the surgery and rehabilitation of patients worldwide, businesses are faced with a myriad of practical and theoretical obstacles.

The Healthcare & Pharmaceutical Awards returns in 2019 to honour those who provide the highest quality of care and medical products available. We also pay homage to those whose innovative work within the pharmaceutical industry contributes towards furthering the advancement of patient care in an ever-expanding and demanding sector.

Sharing their pride in this year’s programme, Katherine Benton, Awards Co-ordinator, commented on the success of these deserving winners: “These awards highlight, beyond a shadow of a doubt, that our winners outshine the competition and are committed to giving their service users the support they need. With the healthcare and pharmaceutical markets among the most important in the entire corporate landscape, I am proud to be able to showcase the winners of this prestigious awards programme for 2019.”

Learn more about XenoTech’s award-winning products and services.

Learn more about: